Tatiana K Deveney1, Bea Herbeck Belnap2, Sati Mazumdar3, Bruce L Rollman4. 1. Kellogg Eye Institute, University of Michigan, Ann Arbor, MI, USA. 2. Division of General Internal Medicine, Center for Behavioral Health and Smart Technology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen, Göttingen, Germany. 3. Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. 4. Division of General Internal Medicine, Center for Behavioral Health and Smart Technology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: rollmanbl@upmc.edu.
Abstract
OBJECTIVE: An American Heart Association (AHA) Science Advisory recommends patients with coronary heart disease undergo routine screening for depressive symptoms with the two-stage Patient Health Questionnaire (PHQ). However, little is known on the prognostic impact of a positive PHQ screen on heart failure (HF) mortality. METHODS: We screened hospitalized patients with systolic HF (left ventricle ejection fraction≤40%) for depression with the two-item Patient Health Questionnaire (PHQ-2) and administered the follow-up nine-item Patient Health Questionnaire (PHQ-9) both immediately following the PHQ-2 and by telephone 1 month after discharge. Later, we ascertained vital status at 4-year follow-up on all patients who completed the inpatient PHQ-9 and calculated mortality incidence and risk by baseline PHQ. RESULTS: Of the 520 HF patients we enrolled, 371 screened positive for depressive symptoms on the PHQ-2. Of these, 63% scored PHQ-9≥10 versus 24% of those who completed the PHQ-9 1 month later (P<.001). PHQ-2 positive status was an independent predictor of 4-year all-cause mortality (HR: 1.50; P=.04), and mortality incidence was similar by baseline PHQ-9 score. CONCLUSIONS: Among hospitalized patients with systolic HF, a positive PHQ-2 screen for depressive symptoms is an independent risk factor for increased 4-year all-cause mortality. Our findings extend the AHA's Science Advisory for depression to hospitalized patients with systolic HF.
OBJECTIVE: An American Heart Association (AHA) Science Advisory recommends patients with coronary heart disease undergo routine screening for depressive symptoms with the two-stage Patient Health Questionnaire (PHQ). However, little is known on the prognostic impact of a positive PHQ screen on heart failure (HF) mortality. METHODS: We screened hospitalized patients with systolic HF (left ventricle ejection fraction≤40%) for depression with the two-item Patient Health Questionnaire (PHQ-2) and administered the follow-up nine-item Patient Health Questionnaire (PHQ-9) both immediately following the PHQ-2 and by telephone 1 month after discharge. Later, we ascertained vital status at 4-year follow-up on all patients who completed the inpatient PHQ-9 and calculated mortality incidence and risk by baseline PHQ. RESULTS: Of the 520 HF patients we enrolled, 371 screened positive for depressive symptoms on the PHQ-2. Of these, 63% scored PHQ-9≥10 versus 24% of those who completed the PHQ-9 1 month later (P<.001). PHQ-2 positive status was an independent predictor of 4-year all-cause mortality (HR: 1.50; P=.04), and mortality incidence was similar by baseline PHQ-9 score. CONCLUSIONS: Among hospitalized patients with systolic HF, a positive PHQ-2 screen for depressive symptoms is an independent risk factor for increased 4-year all-cause mortality. Our findings extend the AHA's Science Advisory for depression to hospitalized patients with systolic HF.
Authors: Tricia J Johnson; Sanjib Basu; Barbara A Pisani; Elizabeth F Avery; Jose C Mendez; James E Calvin; Lynda H Powell Journal: J Card Fail Date: 2012-01-27 Impact factor: 5.712
Authors: Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Patricia R Houck; Fanyin He; Rene J Alvarez; Herbert C Schulberg; Charles F Reynolds; Dennis M McNamara Journal: J Card Fail Date: 2011-12-22 Impact factor: 5.712
Authors: Edward P Havranek; John A Spertus; Frederick A Masoudi; Philip G Jones; John S Rumsfeld Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: Jeff C Huffman; Carol A Mastromauro; Scott R Beach; Christopher M Celano; Christina M DuBois; Brian C Healy; Laura Suarez; Bruce L Rollman; James L Januzzi Journal: JAMA Intern Med Date: 2014-06 Impact factor: 21.873
Authors: Wei Jiang; Maragatha Kuchibhatla; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor Journal: Am Heart J Date: 2007-07 Impact factor: 4.749
Authors: Brett D Thombs; Michelle Roseman; James C Coyne; Peter de Jonge; Vanessa C Delisle; Erin Arthurs; Brooke Levis; Roy C Ziegelstein Journal: PLoS One Date: 2013-01-07 Impact factor: 3.240
Authors: Kenneth E Freedland; Brian C Steinmeyer; Robert M Carney; Judith A Skala; Michael W Rich Journal: Gen Hosp Psychiatry Date: 2020-04-25 Impact factor: 3.238
Authors: Mira-Lynn Chavanon; Thomas Meyer; Birgit Herbeck Belnap; Yan Huang; Kaleab Z Abebe; Bruce L Rollman; Christoph Herrmann-Lingen Journal: J Psychosom Res Date: 2019-08-14 Impact factor: 3.006
Authors: Nqoba Tsabedze; Jamie-Leigh Hayes Kinsey; Dineo Mpanya; Vanessa Mogashoa; Eric Klug; Pravin Manga Journal: Int J Ment Health Syst Date: 2021-05-12